» Articles » PMID: 22387232

Excessive Discounting of Delayed Reinforcers As a Trans-disease Process Contributing to Addiction and Other Disease-related Vulnerabilities: Emerging Evidence

Overview
Journal Pharmacol Ther
Specialty Pharmacology
Date 2012 Mar 6
PMID 22387232
Citations 278
Authors
Affiliations
Soon will be listed here.
Abstract

Delay discounting describes the devaluation of a reinforcer as a function of the delay until its receipt. Although all people discount delayed reinforcers, one consistent finding is that substance-dependent individuals tend to discount delayed reinforcers more rapidly than do healthy controls. Moreover, these higher-than-normal discounting rates have been observed in individuals with other behavioral maladies such as pathological gambling, poor health behavior, and overeating. This suggests that high rates of delay discounting may be a trans-disease process (i.e., a process that occurs across a range of disorders, making findings from one disorder relevant to other disorders). In this paper, we argue that delay discounting is a trans-disease process, undergirded by an imbalance between two competing neurobehavioral decision systems. Implications for our understanding of, and treatment for, this trans-disease process are discussed.

Citing Articles

The amygdala and the pursuit of future rewards.

Johnson S, Grabenhorst F Front Neurosci. 2025; 18:1517231.

PMID: 39911407 PMC: 11794525. DOI: 10.3389/fnins.2024.1517231.


Time Estimation Following an Exhaustive Exercise.

Maci T, Santagati M, Razza G, Petralia M, Massimino S, Rinella S J Funct Morphol Kinesiol. 2025; 10(1.

PMID: 39846676 PMC: 11755588. DOI: 10.3390/jfmk10010035.


Left ventromedial prefrontal cortex inhibitory rTMS as an anti-stress intervention in opioid use disorder: Trial design.

Moses T, Lenz D, Lundahl L, Mischel N, Rabinak C, Greenwald M Contemp Clin Trials Commun. 2025; 43():101414.

PMID: 39802663 PMC: 11719330. DOI: 10.1016/j.conctc.2024.101414.


Delay discounting and symptoms of anxiety and depression in adolescents experiencing challenges with managing type 1 diabetes.

Anderson M, Stanger C Child Health Care. 2025; 54(1):43-58.

PMID: 39760122 PMC: 11698505. DOI: 10.1080/02739615.2023.2226393.


Longitudinal Pathways From Maltreatment to Substance Use Through Delay Discounting During Adolescence and Into Young Adulthood.

Peviani K, Clinchard C, Bickel W, Casas B, Kim-Spoon J JAACAP Open. 2024; 2(4):239-249.

PMID: 39697391 PMC: 11650661. DOI: 10.1016/j.jaacop.2024.02.003.


References
1.
Davis C . Attention-deficit/hyperactivity disorder: associations with overeating and obesity. Curr Psychiatry Rep. 2010; 12(5):389-95. DOI: 10.1007/s11920-010-0133-7. View

2.
Hinson J, Jameson T, Whitney P . Impulsive decision making and working memory. J Exp Psychol Learn Mem Cogn. 2003; 29(2):298-306. DOI: 10.1037/0278-7393.29.2.298. View

3.
Evenden J, Ryan C . The pharmacology of impulsive behaviour in rats: the effects of drugs on response choice with varying delays of reinforcement. Psychopharmacology (Berl). 1996; 128(2):161-70. DOI: 10.1007/s002130050121. View

4.
Heerey E, Matveeva T, Gold J . Imagining the future: degraded representations of future rewards and events in schizophrenia. J Abnorm Psychol. 2010; 120(2):483-9. PMC: 3091996. DOI: 10.1037/a0021810. View

5.
Bobes J, Arango C, Garcia-Garcia M, Rejas J . Healthy lifestyle habits and 10-year cardiovascular risk in schizophrenia spectrum disorders: an analysis of the impact of smoking tobacco in the CLAMORS schizophrenia cohort. Schizophr Res. 2010; 119(1-3):101-9. DOI: 10.1016/j.schres.2010.02.1030. View